Fecal Microbiota Transplantation for Ulcerative Colitis
NCT ID: NCT03804931
Last Updated: 2019-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2/PHASE3
120 participants
INTERVENTIONAL
2019-01-20
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing
NCT02998112
Fecal Microbiota Transplantation for Ulcerative Colitis
NCT03016780
The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis
NCT02435160
Standardized Fecal Microbiota Transplantation for Ulcerative Colitis
NCT01790061
A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis
NCT02058524
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fecal microbiota transplantation
Fecal microbiota transplantation
Fecal microbiota transplantation
200 mL of prepared fecal microbiota suspension from healthy donors' fresh feces was injected into the intestine
5-Aminosalicylic acid(5-ASA) and/or Prednisone
Mesalazine and/or Prednisone
placebo fecal microbiota transplantation
Infusion of Saline
Infusion of Saline
Infusion of Saline
5-Aminosalicylic acid(5-ASA) and/or Prednisone
Mesalazine and/or Prednisone
Traditional treatments
Drug:5-Aminosalicylic acid(5-ASA) and/or Prednisone
5-Aminosalicylic acid(5-ASA) and/or Prednisone
Mesalazine and/or Prednisone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fecal microbiota transplantation
200 mL of prepared fecal microbiota suspension from healthy donors' fresh feces was injected into the intestine
Infusion of Saline
Infusion of Saline
5-Aminosalicylic acid(5-ASA) and/or Prednisone
Mesalazine and/or Prednisone
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Safety using history of 5-ASA
* Able to undergo endoscopy examination
Exclusion Criteria
* High risk of toxic megacolon
* Colon cancer or neoplasia in pathophysiology
* Other severe diseases (eg: cardiovascular, respiratory, gastroenteral and kidney diseases)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guangzhou First People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuqiang Nie, MD
Role: PRINCIPAL_INVESTIGATOR
Guangzhou First People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guangzhou First People's Hospital
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Cui B, Li P, Xu L, Zhao Y, Wang H, Peng Z, Xu H, Xiang J, He Z, Zhang T, Nie Y, Wu K, Fan D, Ji G, Zhang F. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med. 2015 Sep 12;13:298. doi: 10.1186/s12967-015-0646-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K-2017-103-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.